Sign in
Therapeutic compounds
Patent   Open access

Therapeutic compounds

Beverly L Davidson and Ryan L Boudreau
United States Patent and Trademark Office
11/10/2015
pdf
Therapeutic compounds859.72 kBDownloadView
PDM V1.0 Open Access

Abstract

The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.

Details

Metrics

39 File views/ downloads
14 Record Views